Searchable abstracts of presentations at key conferences in endocrinology

ea0013p156 | Diabetes, metabolism and cardiovascular | SFEBES2007

Reliability on clinical features or GAD antibody measurements – which is better for diagnosis of LADA?

Anand Shweta , Das Gautam , North Jonathan , De Parijat

Introduction: Latent Autoimmune Diabetes of Adult (LADA) is a form of adult onset type1diabetes. It usually presents after age 30 years and has many demonstrable antibodies, Glutamic Acid Decarboxylase (GAD) being one of them. Detection of LADA has definite prognostic and treatment implications as 10% of adults with diabetes in UKPDS had LADA and majority of them required insulin within 6 years of diagnosis. Screening by using GAD antibody has been said to be a superior method...